Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	70.84	47.83	27.99
Graham Fair Price	58.12	3.68	2.32
PEG	91.39	-0.02	-0.18
Price/Book	25.03	0.35	0.28
Price/Cash Flow	-14.43	-1.96	2.29
Prices/Earnings	-73.40	9.99	37.54
Price/Sales	281.55	1.90	0.50
Price/FCF	-14.43	-1.96	2.29
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	57.99	0.26	0.17
Operating Margin	273.17	0.08	0.02
ROA	378.47	< 0.005	< 0.005
ROE	< 0.005	< 0.005	370.05
ROIC	< 0.005	< 0.005	117.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.11	-0.10	18.38
Dividends QOQ	-0.54	-0.09	83.01
EBIT QOQ	1.92	0.23	-87.89
EPS QOQ	-2.09	6.46	209.00
FCF QOQ	2.37	-2.47	4.24
Revenue QOQ	1.05	-0.67	-36.12
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	77.83	304.80	291.63
Days Sales Outstanding (DSO)	132.00	356.73	170.25
Inventory Turnover	1.16	0.30	-74.47
Debt/Capitalization	0.50	0.53	4.99
Quick Ratio	0.73	0.66	-8.87
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.34	8.27	-27.07
Cash	4.51	2.48	-44.99
Capex	-0.60	-0.16	73.69
Free Cash Flow	1.39	-1.48	6.57
Revenue	6.37	1.52	-76.10
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.01	1.08	6.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.34	33.55	73.52
Naive Interpretation	Member

06 - Financial Health · Bad

Rating